MENU
ALVR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AlloVir (ALVR) Ownership - Who owns AlloVir?
AlloVir Inc is a late clinical-stage cell therapy company... Show more
Profile
Industry
N/A
Address
1100 Winter Street
Phone
+1 617 433-2605
Employees
112
Web
https://www.allovir.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
49.76M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ALVR
Capitalization
49.8M
P/E Ratio
N/A
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
121M
P/B Ratio
0.41
Cash Flow
N/A
Earnings
-20.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
86.78
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-79.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-54.04
Shares Held By Institutions
37.2M
Shares Outstanding - Current
5.04M
Total Liabilities
1.41M
Total Volume MTD
N/A
Value
1
Gain YTD
-4.762
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1100 Winter Street
Phone
+1 617 433-2605
Employees
112
Web
https://www.allovir.com